relacorilant,enzalutamide
corcept therapeutics,pfizer,Astellas
['enzalu', 'enzalutamide', 'relacorilant', 'prostate']
great data showing no adverse events with dose escalation of #enzalutamide (120) + #relacorilant (150) treatment in metastatic castration resistant #prostatecancer patients. #asco23 
Official Twitter of the NCI-designated University of Chicago Medicine Comprehensive Cancer Center, Chicago, IL USA. #WeAreNCIDesignated #NothingWillStopUs